|
|
|
|
| LEADER |
01854nmm a2200301 u 4500 |
| 001 |
EB000374242 |
| 003 |
EBX01000000000000000227294 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
130626 ||| eng |
| 020 |
|
|
|a 9783540297154
|
| 100 |
1 |
|
|a Kass, Robert E.
|e [editor]
|
| 245 |
0 |
0 |
|a Basis and Treatment of Cardiac Arrhythmias
|h Elektronische Ressource
|c edited by Robert E. Kass, Colleen E. Clancy
|
| 250 |
|
|
|a 1st ed. 2006
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 2006, 2006
|
| 300 |
|
|
|a IX, 361 p. 66 illus., 4 illus. in color
|b online resource
|
| 505 |
0 |
|
|a History of Arrhythmias -- Pacemaker Current and Automatic Rhythms: Toward a Molecular Understanding -- Proarrhythmia -- Cardiac Na+ Channels as Therapeutic Targets for Antiarrhythmic Agents -- Structural Determinants of Potassium Channel Blockade and Drug-Induced Arrhythmias -- Sodium Calcium Exchange as a Target for Antiarrhythmic Therapy -- A Role for Calcium/Calmodulin-Dependent Protein Kinase II in Cardiac Disease and Arrhythmia -- AKAPs as Antiarrhythmic Targets? -- ?-Blockers as Antiarrhythmic Agents -- Experimental Therapy of Genetic Arrhythmias: Disease-Specific Pharmacology -- Mutation-Specific Pharmacology of the Long QT Syndrome -- Therapy for the Brugada Syndrome -- Molecular Basis of Isolated Cardiac Conduction Disease -- hERG Trafficking and Pharmacological Rescue of LQTS-2 Mutant Channels
|
| 653 |
|
|
|a Cardiology
|
| 653 |
|
|
|a Human Physiology
|
| 653 |
|
|
|a Human physiology
|
| 653 |
|
|
|a Pharmacology
|
| 700 |
1 |
|
|a Clancy, Colleen E.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 490 |
0 |
|
|a Handbook of Experimental Pharmacology
|
| 028 |
5 |
0 |
|a 10.1007/3-540-29715-4
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/3-540-29715-4?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615
|